Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Enhanced cytotoxicity against cholangiocarcinoma by fifth-generation chimeric antigen receptor T cells targeting integrin αvβ6 and secreting anti-PD-L1 scFv

Fig. 3

Assessment of the re-challenge killing potential and long-term antitumor efficacy of CAR T cells against KKU-213A cells. A Schematic diagram of the re-challenge killing experiment. A20 CAR T cells were co-cultured with KKU-213A target cells at a 5:1 effector-to-target (E:T) ratio. Antigenic stimulation was performed every three days for a total of three cycles over a 9-day period. B Cytotoxicity percentages of A20 CAR4 T and A20 CAR5 T cells against target cells were assessed through a flow cytometry-based assay. C Timeline and schematic of the long-term antigen challenge, showing CAR T cell proliferation following co-culture with KKU-213A cells at an E:T ratio of 2:1 for 6 days. D Cytotoxicity in the long-term antigen challenge assay, assessed via crystal violet staining. E Percentage of cytotoxicity by A20 CAR4 T and A20 CAR5 T cells against target cells after prolonged antigen challenge on days 3 and 6. Data from three individual healthy donors are presented as the mean ± SEM. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001)

Back to article page